|
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT |
|
(Exact name of registrant as specified in its charter) |
|
|
|
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
N/A |
|
|
(Former name or former address, if changed since last report) |
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
|
|
|
Large accelerated filer |
¨ |
Accelerated filer |
¨ |
|
x |
Smaller reporting company |
|
|
Emerging growth company |
|
2 |
F-1 |
June 30, | December 31, | |||||||
2023 | 2022 | |||||||
ASSETS | ||||||||
Current Assets | ||||||||
Cash and cash equivalents | $ | $ | ||||||
Accounts receivable | ||||||||
Inventory, net | ||||||||
Advances to suppliers | ||||||||
Security deposits | ||||||||
Prepaid expenses and other current assets | ||||||||
Total Current Assets | ||||||||
Non-Current Assets | ||||||||
Property, plant and equipment, net | ||||||||
Other non-current assets | ||||||||
Operating lease right of use asset | ||||||||
Loans receivable from related parties, net | ||||||||
Total Non-Current Assets | ||||||||
Total Assets | ||||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current Liabilities | ||||||||
Other payable and accrued expenses | ||||||||
Due to shareholders | ||||||||
Income taxes payable | ||||||||
Other current liabilities | ||||||||
Operating lease liabilities - current | ||||||||
Current portion of long-term loan payables | ||||||||
Total Current Liabilities | ||||||||
Non-Current Liabilities | ||||||||
Long-term loan payables | ||||||||
Operating lease liabilities - non-current | ||||||||
Total Non-Current Liabilities | ||||||||
Total Liabilities | ||||||||
Commitments and Contingencies | ||||||||
Shareholders’ Equity | ||||||||
Preferred stock ($ res issued and outstanding as of June 30, 2023 and | ||||||||
Common stock ($ issued and outstanding as of June 30, 2023 and December 31, 2022, respectively) | ||||||||
Additional paid in capital | ||||||||
Deferred stock compensation | ( | ) | ( | ) | ||||
Retained earnings | ( | ) | ( | ) | ||||
Accumulated other comprehensive loss | ||||||||
Total equity attributable to EOS, Inc. | ( | ) | ( | ) | ||||
Non-controlling interest | ( | ) | ( | ) | ||||
Total Equity | ( | ) | ( | ) | ||||
Total Liabilities and Shareholders’ Equity | $ | $ |
F-2 |
|
|
Three Months Ended |
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
Six Months Ended |
|
||||
|
|
June 30, |
|
|
June 30, |
|
|
June 30, |
|
|
June 30, |
|
||||
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
Net sales |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Cost of sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (Loss) from operations |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income (expense) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other income (expense) |
|
|
( |
) |
|
|
|
|
|
|
( |
) |
|
|
|
|
Loss before income tax provision |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Income tax expenses (benefits) |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
( |
) |
Net Loss |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Comprehensive Income (Loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to non-controlling interests |
|
$ |
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Net income (loss) attributable to EOS and subsidiaries |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Foreign currency translation adjustment, net of tax |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
( |
) |
Comprehensive loss |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Weighted average number of common shares: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
Equity |
|
|
|
|
|
||||
|
Common Stock |
Preferred Stock |
Deferred |
Additional |
|
|
other |
attributable |
Non- |
|||||||||||||||||||||||||
|
|
Number of |
|
|
|
Number of |
|
|
|
Stock |
|
Paid-in |
|
Retained |
|
Comprehensive |
|
to |
|
Controlling |
|
Total |
|
|||||||||||
|
Shares |
Amount |
Shares |
Amount |
Compensation |
Capital |
Earnings |
Income (Loss) |
EOS, Inc. |
interest |
Equity |
|
||||||||||||||||||||||
Balance at December 31, 2021 |
|
|
|
|
|
|
$ |
|
|
|
|
$ |
- |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
||
Foreign currency translation adjustment |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
( |
) |
|
( |
) |
|
( |
) |
|
( |
) |
Net loss |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
( |
) |
|
- |
|
|
( |
) |
|
( |
) |
|
( |
) |
Balance at March 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share issued for compensation |
|
|
|
|
|
|
|
|
- |
|
|
- |
|
|
- |
|
|
|
|
|
- |
|
|
- |
|
|
|
|
|
- |
|
|
|
|
Deferred compensation expense relating to issuance of restricted common stock |
|
|
|
|
|
|
|
|
- |
|
|
- |
|
|
( |
) |
|
|
|
|
- |
|
|
- |
|
|
|
|
|
- |
|
|
|
|
Deferred compensation expense relating to issuance of warrant |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
( |
) |
|
|
|
|
- |
|
|
- |
|
|
|
|
|
- |
|
|
|
|
Foreign currency translation adjustment |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
( |
) |
|
( |
) |
|
( |
) |
|
( |
) |
Net loss |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
( |
) |
|
- |
|
|
( |
) |
|
( |
) |
|
( |
) |
Balance at June 30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
( |
) |
|
|
|
|
( |
) |
|
( |
) |
|
( |
) |
Foreign currency translation adjustment |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
( |
) |
|
( |
) |
|
( |
) |
|
( |
) |
Net loss |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
( |
) |
|
- |
|
|
( |
) |
|
( |
) |
|
( |
) |
Balance at March 31, 2023 |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
( |
) |
$ |
|
|
$ |
( |
) |
$ |
|
|
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
Foreign currency translation adjustment |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
( |
) |
|
- |
|
|
( |
) |
|
( |
) |
|
( |
) |
Balance at June 30, 2023 |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
( |
) |
$ |
|
|
$ |
( |
) |
$ |
|
|
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
F-4 |
|
|
Six Months Ended |
|
|
Six Months Ended |
|
||
|
|
June 30, |
|
|
June 30, |
|
||
|
|
2023 |
|
|
2022 |
|
||
Cash flows from operating activities |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
( |
) |
|
$ |
( |
) |
Adjustments to reconcile net income to net cash provided by operating activities |
|
|
- |
|
|
|
- |
|
Bad debt recovery |
|
|
|
|
|
|
( |
) |
Depreciation |
|
|
|
|
|
|
|
|
Amortization of right-of-use asset |
|
|
|
|
|
|
|
|
Stock based compensation |
|
|
|
|
|
|
|
|
Changes in assets and liabilities |
|
|
- |
|
|
|
- |
|
Decrease in accounts receivable |
|
|
|
|
|
|
|
|
I ncrease in inventory |
|
|
( |
) |
|
|
( |
) |
Decrease in advance to suppliers |
|
|
|
|
|
|
|
|
Decrease (increase) in security deposits and other assets |
|
|
|
|
|
|
( |
) |
Increase |
|
|
|
|
|
|
|
|
Increase in accrued expenses |
|
|
|
|
|
|
|
|
Dec rease in advances from customers |
|
|
( |
) |
|
|
|
|
Increase (decreas in income tax payablee) |
|
|
|
|
|
|
( |
) |
D ecrease in operating lease liabilities |
|
|
|
|
|
|
( |
) |
Net cash |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
Purchase of equipment |
|
|
( |
) |
|
|
( |
) |
Net cash used in investing activities |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
|
|
|
Repayment to related party |
|
|
( |
) |
|
|
( |
) |
Proceeds from related party |
|
|
|
|
|
|
|
|
Repayment to borrowings |
|
|
( |
) |
|
|
( |
) |
Net cash provided by financing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of foreign currency translation on cash and cash equivalents |
|
|
( |
) |
|
|
( |
) |
Net increase of cash and cash equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents, and restricted cash |
|
|
|
|
|
|
|
|
Beginning |
|
|
|
|
|
|
|
|
Ending |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
Supplemental Disclosure of Cash Flows |
|
|
|
|
|
|
|
|
Cash paid during the periods for: |
|
|
|
|
|
|
|
|
Interest |
|
$ |
|
|
|
$ |
|
|
Income taxes |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
Non-cash financing and investing activities: |
|
|
|
|
|
|
|
|
Deferred compensation expense relating to issuance of restricted common stock |
|
$ |
|
|
|
$ |
|
|
Deferred compensation expense relating to issuance of warrant |
|
$ |
|
|
|
$ |
|
|
F-5 |
F-6 |
F-7 |
F-8 |
For the six months ended June 30, 2023: |
||||
Nutrition supplement | $ | |||
Software | ||||
Other | ||||
Total | $ | |||
For the six months ended June 30, 2022: |
||||
Water purifier machine | $ | |||
Automobile carbon reduction machine | ||||
Nutrition supplement | ||||
Software | ||||
Other | ||||
Total | $ |
For the six months ended June 30, 2023: |
|
|
|
|
Asia Pacific |
|
$ |
|
|
Total |
|
$ |
|
|
For the six months ended June 30, 2022: |
|
|
|
|
Asia Pacific |
|
$ |
|
|
Total |
|
$ |
|
|
F-9 |
F-10 |
F-11 |
Customer |
|
Net sales for the six months ended June 30, 2023 |
|
|
% of Total |
|
|
Accounts receivable balance as of June 30, 2023 |
|
|
% of Total |
|
||||
A |
|
$ |
|
|
|
|
|
% |
|
$ |
|
|
|
|
|
% |
B |
|
$ |
|
|
|
|
|
% |
|
$ |
|
|
|
|
|
% |
Customer |
|
|
Net sales for the six months ended June 30, 2022 |
|
|
% of Total |
|
|
Accounts receivable balance as of June 30, 2022 |
|
|
% of Total |
|
|||||||||||||||||||||||||||||||
A |
|
|
$ |
|
|
|
|
|
|
|
|
|
% |
|
$ |
|
|
|
|
|
% |
|||||||||||||||||||||||
B
|
|
|
$
|
|
|
|
|
|
|
|
|
%
|
|
$
|
|
|
|
|
|
%
|
F-12 |
Supplier | Net purchase for the six months ended June 30, 2023 | % of Total | Accounts payable balance as of June 30, 2023 | % of Total | ||||||||||||
A | $ | % | $ | % |
Supplier | Net purchase for the six months ended June 30, 2022 | % of Total | Accounts payable balance as of June 30, 2022 | % of Total | ||||||||||||
A | $ | % | $ | % | ||||||||||||
B | $ | % | $ | % |
F-13 |
Lease Cost |
June 30, 2023 |
June 30, 2022 |
||||||
Operating lease cost (included in general and administrative expenses in the Company’s statement of operations) |
$ |
|||||||
Other Information |
||||||||
Right-of-use assets obtained in exchange for new operating leases liabilities |
||||||||
Cash paid for amounts included in the measurement of lease liabilities |
||||||||
Weighted average remaining lease term – operating leases (in years) |
||||||||
Average discount rate – operating lease |
% |
% |
June 30, 2023 |
December 31, 2022 |
|||||||
Operating leases | ||||||||
Right-of-use assets, net | $ | $ | ||||||
Operating lease liabilities | $ | $ |
For the periods ending June 30, |
||||
2023 (six months remaining) |
||||
2024 |
||||
2025 |
||||
2026 |
||||
Total lease payments |
||||
Less: Interest |
( |
) |
||
Total |
F-14 |
Name of Related Party |
|
Nature of Relationship |
Yu Cheng Yang |
|
Majority Shareholder, Director and Officer of the Company |
Co-Innovation Group Limited |
|
Company under control of Yu Cheng Yang |
World Capital Holding Limited |
|
Company under control by Shanghai Qifan Qiye Management Co., Ltd.’s shareholders, former non-controlling interest of the Company |
F-15 |
|
|
Number of Shares |
|
|
Weighted Average Exercise Price |
|
|
Weighted Average Remaining Contractual Term (Years) |
|
|||
|
|
|
|
|
|
|
|
|
|
|||
Warrants outstanding at December 31, 2022 |
|
|
|
|
|
$ |
|
|
|
|
|
|
Granted |
|
|
|
|
|
|
|
|
|
|
- |
|
Exercised |
|
|
|
|
|
|
|
|
|
|
- |
|
Expired |
|
|
|
|
|
|
|
|
|
|
- |
|
Warrants outstanding at June 30, 2023 |
|
|
|
|
|
$ |
|
|
|
|
|
|
Warrants exercisable at June 30, 2023 |
|
|
|
|
|
$ |
|
|
|
|
|
|
F-16 |
|
|
Years Ended December 31, |
|
|||||
|
|
2022 |
|
|
2021 |
|
||
Expected life (years) |
|
|
|
|
|
|
N/A |
|
Risk-free interest rate |
|
|
|
% |
|
|
N/A |
|
Expected volatility |
|
|
|
% |
|
|
N/A |
|
Dividend yield |
|
|
|
% |
|
|
N/A |
|
F-17 |
Six months ended June 30, | ||||||||
2023 | 2022 | |||||||
Current income tax (benefit) | ||||||||
U.S. | $ | $ | ||||||
Taiwan | ||||||||
PRC | ||||||||
Sub total | ||||||||
Deferred income tax | ||||||||
Deferred tax assets for NOL carry-forwards | ( | ) | ( | ) | ||||
Valuation allowance | ||||||||
Other adjustments | ||||||||
Net changes in deferred income tax (benefit) | ||||||||
Total income tax provision | $ | $ |
Six months ended June 30, | ||||||||
2023 | 2022 | |||||||
Net loss before income tax | ( | ) | ( | ) | ||||
Effective statutory tax rate | % | % | ||||||
Income tax provision | ( | ) | ( | ) | ||||
Computed expected benefit | ||||||||
Valuation allowance | ||||||||
Non-taxable income | ||||||||
Other adjustments, primarily the difference in tax rates | ( | ) | ||||||
Income tax expenses, net |
Deferred tax assets: | June 30, 2023 | December 31, 2022 | ||||||
Net operating loss carry-forwards | ||||||||
Less: Valuation allowance | ( | ) | ( | ) | ||||
Deferred tax assets, net |
F-18 |
F-19 |
3 |
4 |
5 |
6 |
Exhibit No. | Description | |
31.1 | Certification of Chief Executive and Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. | |
32.1 | Certification of Chief Executive and Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
101.INS | XBRL Instance Document | |
101.SCH | XBRL Taxonomy Extension Schema Document | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | |
104 | Cover Page Interactive Data File - the cover page from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, is formatted in Inline XBRL. |
7 |
EOS Inc. | ||
Date: August 14, 2023 | By: | /s/ He-Siang Yang |
He-Siang Yang | ||
CEO, President, Secretary and Chairman of the Board |
8 |